... Etranacogene dezaparvovec-drlb (Hemgenix) is approved to treat hemophilia B, and valoctocogene roxaparvovec-rvox (Roctavian) is approved for severe hemophilia A. ...
... Etranacogene dezaparvovec-drlb (Hemgenix) is approved to treat hemophilia B, and valoctocogene roxaparvovec-rvox (Roctavian) is approved for severe hemophilia A. ...
... With a working copy of the gene, a person with hemophilia may be able to make the missing clotting factor on their own.Valoctocogene roxaparvovec-rvox (Roctavian) is FDA-approved to treat severe hemophilia A. Etranacogene dezaparvovec-drlb (Hemgenix) is a gene therapy approved for hemophilia B. ...
... With a working copy of the gene, a person with hemophilia may be able to make the missing clotting factor on their own.Valoctocogene roxaparvovec-rvox (Roctavian) is FDA-approved to treat severe hemophilia A. Etranacogene dezaparvovec-drlb (Hemgenix) is a gene therapy approved for hemophilia B. ...